Recent studies have developed a gene therapy approach utilizing dendrimer–graphite nanoparticles to selectively enhance RNF41 expression in macrophages, leading to notable improvements in hepatic fibrosis and regeneration in liver injury mouse models [40]. Here, RNF41 is linked to fibrosis.